This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Ill-defined sites within the digestive system
CD2_BENIGN_DIGESTIVE_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum systematis digestorii loco male specificato
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Ill-defined sites within the digestive system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Ill-defined sites within the digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 208 | 137 | 71 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 61.18 | 59.51 | 64.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 186
- Matched controls
- 1859
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
+∞
205.2
157
*
130
Kela drug reimbursment
Malignant tumour
+∞
25.6
24
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
50.0
22.0
26
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.6
19.4
31
22
21199
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Unspecified site
+∞
19.1
18
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
16.9
16
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
23.6
16.4
23
11
A04AA02
ATC
granisetron; systemic, transdermal
+∞
14.8
14
*
115
Kela drug reimbursment
Breast cancer
+∞
13.7
13
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
30.9
13.2
17
6
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
13.1
51
144
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
+∞
12.6
12
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
50.1
12.0
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
11.7
37
83
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.8
11.6
41
104
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.5
11.1
29
51
H02AB02
ATC
dexamethasone; systemic
19.3
10.9
16
9
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
A02BC02
ATC
pantoprazole; systemic
3.0
10.5
139
923
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
10.0
64
266
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
9.8
79
380
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
9.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
9.3
82
415
UJF32
NOMESCO Finland
Coloscopy
2.9
8.9
66
300
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.4
8.7
15
13
N02AX02
ATC
tramadol; systemic, rectal
2.6
8.7
95
538
WX402
NOMESCO Finland
General anaesthesia
3.6
8.5
40
131
L02BG04
ATC
letrozole; oral
94.1
8.5
9
*
JAH00
NOMESCO Finland
Laparotomy
10.2
8.5
16
17
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
8.4
8
*
2119X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Other and unspecified site[NEOPLASMA BENIGNUM ALIUD ORG DIGEST AL DEF SEU NUD]
+∞
8.4
8
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
5.8
8.3
23
44
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
8.2
64
295
ZXE00
NOMESCO Finland
One hour or less
2.4
7.5
89
514
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
83.2
7.5
8
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
7.3
7
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
7.3
7
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
31.3
7.2
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
7.0
48
203
B01AB05
ATC
enoxaparin; parenteral
2.5
6.9
66
339
K83.1
ICD-10 Finland
Obstruction of bile duct
41.6
6.8
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
6.8
20
42
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
9.2
6.7
13
15
R4110
NOMESCO Finland
Physiotherapy
2.6
6.6
56
266
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
72.2
6.5
7
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
72.2
6.5
7
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.9
6.4
20
45
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
JFB00
NOMESCO Finland
Partial resection of small intestine
27.7
6.3
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
6.1
44
192
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
59
94
8.37
37.81
4.4
1.3
ug/l
13.9
2.7
1.16
47
74
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
43
9.92
28.78
2.6
1.6
u/ml
582.1
10.1
0.50
28
32
(4035726)
32
42
8.82
23.63
1.7
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
156
5.00
22.44
3.7
2.4
umol/l
6.6
5.3
0.26
54
135
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
15
13.04
18.04
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
48
125
4.69
17.63
1.6
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
50
6.58
16.69
1.3
1.3
ug/g
281.0
315.4
0.28
20
24
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
45
117
4.63
16.50
2.9
1.9
g/l
0.2
0.2
0.48
45
104
(3024561) Albumin [Mass/volume] in Serum or Plasma
128
691
3.22
15.07
6.6
3.2
g/l
35.2
35.7
0.48
121
631
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
19
7
29.65
14.55
4.4
1.0
nmol/l
4.9
5.4
—
19
7
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
46
136
4.06
14.15
3.1
2.1
u/l
34.5
30.0
0.46
46
110
(3026782) Osmolality of Urine
70
305
2.95
11.46
2.2
2.5
mosm/kgh2o
511.5
540.1
0.48
62
257
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
96
510
2.64
10.56
3.7
2.5
u/l
34.4
30.8
0.44
91
485
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
100
544
2.61
10.45
3.5
2.0
u/l
62.1
56.1
0.76
93
497
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
128
792
2.60
10.11
7.3
5.2
mmol/l
1.2
1.2
0.26
106
689
(3000991) Gas panel - Venous blood
37
124
3.41
9.29
5.2
6.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
77
395
2.51
8.80
5.3
3.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
55
239
2.77
8.80
1.5
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
80
423
2.45
8.52
3.4
2.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
84
461
2.38
8.17
7.2
3.1
ph
7.4
7.4
0.67
20
73
(3002582) Erythrocytes [#/volume] in Urine
86
485
2.32
7.78
3.4
2.9
e6/l
13.0
44.8
1.98
62
363
(40768804) Tissue Pathology biopsy report
91
526
2.30
7.77
2.9
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
112
710
2.25
7.60
7.9
4.8
mmol/l
1.2
1.2
0.19
107
634
(3030467) Casts [#/volume] in Urine by Automated count
80
442
2.32
7.55
3.4
2.8
e6/l
0.2
0.6
2.03
56
316
(3032080) INR in Blood by Coagulation assay
108
680
2.22
7.39
9.5
8.5
inr
1.2
1.3
0.38
36
191
(3000850) Epithelial cells [#/volume] in Urine
64
325
2.40
7.29
2.4
2.2
e6/l
7.6
5.6
0.31
53
288
(3022948) Iron [Moles/volume] in Serum or Plasma
52
240
2.56
7.27
2.6
2.2
umol/l
12.5
13.5
0.46
46
212
(3013650) Neutrophils [#/volume] in Blood by Automated count
127
863
2.21
7.07
17.1
6.2
e9/l
4.0
4.3
0.51
106
747
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
190
2.67
7.02
2.9
2.4
%
19.6
23.6
1.12
37
163
(3018095) Leukocytes [#/volume] in Urine
94
575
2.16
6.76
3.9
3.5
e6/l
98.8
153.0
0.37
67
396
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
80
3.42
6.69
5.6
6.8
mmol/l
24.3
25.2
0.57
25
80
(3014576) Chloride [Moles/volume] in Serum or Plasma
43
188
2.62
6.68
5.1
5.4
mmol/l
103.6
104.1
0.36
43
182
(42870588) Differential panel, method unspecified - Blood
86
510
2.17
6.68
6.2
5.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
166
1280
2.47
6.55
13.2
5.1
u/l
85.2
76.1
1.41
161
1160
(3013826) Glucose [Moles/volume] in Serum or Plasma
136
975
2.14
6.29
5.3
4.1
mmol/l
7.1
6.7
0.83
130
899
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
73
3.42
6.23
4.3
8.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
106
697
2.06
6.13
7.8
5.0
%
0.6
0.7
0.60
100
638
(3042936) Bacteria identified in Isolate by Culture
45
216
2.38
5.70
2.9
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
90
570
2.02
5.66
3.4
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
37
163
2.54
5.62
1.6
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
108
735
1.98
5.48
7.6
5.0
%
58.7
57.7
0.40
102
678
(3002030) Lymphocytes/100 leukocytes in Blood
108
738
1.96
5.39
7.9
5.3
%
25.5
27.6
1.32
102
676
(3019069) Monocytes/100 leukocytes in Blood
107
730
1.96
5.36
7.9
5.4
%
8.7
8.4
0.49
101
675
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
706
1.95
5.25
5.3
3.5
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
0
+∞
5.23
2.0
0.0
u/l
106.0
—
—
5
0
(3006504) Eosinophils/100 leukocytes in Blood
106
727
1.93
5.17
7.9
5.1
%
3.0
2.8
0.26
100
669
(3021589) Normoblasts [#/volume] in Blood
105
718
1.93
5.16
16.1
7.9
e9/l
0.0
0.0
0.69
83
581
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
102
2.77
4.94
1.4
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
39
190
2.30
4.74
7.1
4.3
mmol/l
1.1
1.0
0.16
39
170
(40761536) Microorganisms panel - Urine sediment
29
124
2.56
4.67
3.8
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
154
1227
1.98
4.49
4.0
3.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
109
786
1.81
4.28
8.1
4.9
e9/l
0.0
0.0
0.00
89
678
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
170
2.27
4.27
1.7
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
111
807
1.81
4.22
10.1
5.0
e9/l
0.2
0.2
0.17
93
704
(3044640) Blood type and Crossmatch panel - Blood
71
450
1.88
4.22
3.3
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
27
4.25
4.22
1.4
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
108
780
1.80
4.19
8.1
4.9
e9/l
0.6
0.6
0.21
88
671
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
46
254
2.04
4.07
3.2
2.9
e6/l
4.9
3.1
0.17
17
123
(3018677) aPTT in Platelet poor plasma by Coagulation assay
44
239
2.07
4.06
1.8
1.7
s
29.7
29.2
0.28
44
232
(3019198) Lymphocytes [#/volume] in Blood
109
796
1.78
4.02
8.2
5.0
e9/l
1.7
1.9
0.69
92
691
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
336
1.91
3.90
3.4
3.7
ng/l
181.2
87.5
0.33
45
264
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
170
2.20
3.87
4.6
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
180
2.14
3.71
4.0
5.7
mmol/l
0.9
1.7
0.61
25
138
(4062490)
9
16
5.82
3.70
1.2
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
57
350
1.87
3.68
11.0
4.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
44
248
1.98
3.66
1.7
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
97
700
1.72
3.62
2.9
2.3
nmol/l
80.7
78.6
0.28
86
606
(3001122) Ferritin [Mass/volume] in Serum or Plasma
97
703
1.71
3.54
3.6
2.6
ug/l
127.9
107.5
0.56
90
638
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
169
2.13
3.54
1.7
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
27
3.84
3.39
1.8
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
76
524
1.71
3.27
2.7
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
46
273
1.88
3.27
3.2
2.7
e6/l
0.6
1.0
1.08
16
140
(3002385) Erythrocyte distribution width [Ratio]
162
1369
1.83
3.25
32.7
14.3
%
13.9
13.6
2.02
157
1335
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
316
1.81
3.16
5.8
2.1
mmol/l
2.4
2.4
0.36
46
266
(3021447) Carbon dioxide [Partial pressure] in Venous blood
31
164
2.05
3.06
3.5
3.4
kpa
6.0
5.9
0.26
31
158
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
5
10.20
2.99
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
17
4.85
2.95
1.6
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
226
0.37
2.76
11.4
6.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
6
8.50
2.76
1.4
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
52
337
1.72
2.75
3.1
2.0
—
—
—
0
0
(3012544) pH of Venous blood
31
171
1.96
2.73
3.5
3.5
—
—
—
0
0
(44806118)
6
10
6.14
2.71
1.3
1.0
—
—
—
0
0
(44790049)
6
10
6.14
2.71
1.3
1.0
—
—
—
0
0
(44790047)
6
10
6.14
2.71
1.3
1.0
—
—
—
0
0
(44790048)
6
10
6.14
2.71
1.3
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
24
3.87
2.70
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
26
3.57
2.51
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
26
3.57
2.51
1.6
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
21
3.92
2.49
1.4
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
27
3.44
2.42
1.7
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
129
1067
1.55
2.40
4.5
3.0
u/l
64.2
46.7
0.99
120
987
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
58
405
1.60
2.28
2.9
2.1
mg/l
3.5
3.1
0.42
53
332
(40768441) Liver Pathology biopsy report
5
9
5.66
2.22
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
9
5.66
2.22
1.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
25
3.29
2.12
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
69
2.27
2.10
1.1
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
69
2.27
2.10
1.1
1.1
g/l
7.6
7.7
—
8
53
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
69
2.27
2.10
1.1
1.1
g/l
4.0
4.0
—
8
51
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.09
2.08
1.4
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
24
134
1.89
2.06
2.6
2.7
kpa
4.0
4.3
0.45
24
127
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
32
2.89
2.02
1.9
1.5
mu/l
233.1
308.4
—
9
32
(3037467) Urinalysis macro (dipstick) panel - Urine
136
1162
1.49
1.99
4.8
4.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
64
2.27
1.99
1.1
1.1
g/l
3.1
3.1
—
8
52
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
7
21
3.41
1.98
1.4
1.1
u/l
59.3
59.0
—
7
14
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
185
1697
1.82
1.97
25.2
11.9
mg/l
27.6
21.3
1.64
159
1286
(3016018) Differential panel - Cerebral spinal fluid
5
11
4.63
1.95
1.2
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
16
3.83
1.95
1.5
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
60
437
1.52
1.94
3.1
2.3
umol/l
325.8
8294.6
2.50
54
379
(3025941) Bacteria identified in Stool by Culture
18
93
2.02
1.92
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
34
2.72
1.89
2.4
3.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
8
28
2.93
1.88
1.5
1.3
pmol/l
61.0
65.8
—
8
28
(3000492) Spirometry study
24
139
1.82
1.85
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
31
194
1.70
1.85
2.0
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
109
1.92
1.85
3.6
4.6
%
0.2
0.1
—
5
22
(3012516) Albumin [Mass/volume] in Urine
73
559
1.47
1.84
2.8
3.2
mg/l
1837.3
170.2
0.70
44
345
(3035350) Ketones [Presence] in Urine by Test strip
103
843
1.44
1.83
3.7
3.7
estimate
0.0
0.0
0.00
25
148
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
92
739
1.44
1.80
2.3
2.0
pmol/l
96.9
95.9
0.07
45
361
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
41
2.51
1.78
1.3
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
20
111
1.89
1.76
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
18
3.40
1.76
1.3
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
13
3.91
1.72
1.4
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
13
3.91
1.72
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
198
1.66
1.72
1.4
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
25
2.86
1.66
2.6
2.5
%
65.1
58.6
—
7
25
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
91
1.95
1.66
1.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
1.6
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
26
2.75
1.59
2.3
1.1
nmol/l
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
26
2.75
1.59
1.6
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
20
3.06
1.59
1.2
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
115
1.82
1.59
3.6
4.4
%
0.2
0.8
—
5
25
(3019550) Sodium [Moles/volume] in Serum or Plasma
192
1802
1.85
1.58
25.4
14.6
mmol/l
139.3
139.8
1.98
187
1745
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
93
1.90
1.57
3.8
3.9
pmol/l
4.1
4.4
1.30
17
81
(40760892) CBC W Ordered Manual Differential panel - Blood
46
331
1.50
1.56
6.0
4.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
15
3.39
1.53
1.6
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
15
3.39
1.53
1.4
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
21
2.91
1.51
2.3
1.6
—
—
—
0
0
(4306422)
6
21
2.91
1.51
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
87
1.91
1.50
1.1
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
102
854
1.38
1.50
5.0
5.0
estimate
0.0
0.0
0.00
22
143
(3023103) Potassium [Moles/volume] in Serum or Plasma
192
1807
1.81
1.49
25.9
14.6
mmol/l
4.0
4.0
0.78
187
1750
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
95
1.86
1.48
1.4
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
193
1820
1.84
1.47
27.0
14.2
umol/l
80.8
76.4
0.72
193
1820
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
39
2.37
1.45
2.1
2.3
mg/l
1.3
1.6
—
9
34
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
29
2.46
1.40
1.7
2.3
—
—
—
0
0
(4024509)
5
17
2.99
1.36
1.2
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
133
0.43
1.33
3.8
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
102
866
1.35
1.33
3.9
3.7
estimate
0.0
0.0
0.00
24
146
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
24
2.54
1.31
2.5
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
46
343
1.44
1.30
2.1
1.6
mg/l
1.3
1.1
0.21
41
264
(3027945) Reticulocytes/100 erythrocytes in Blood
27
180
1.57
1.29
4.1
2.2
%
1.8
1.5
0.79
21
161
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
237
0.56
1.28
4.1
4.9
%
30.3
32.6
—
7
152
(40760888) Immunoglobulin light chains.free panel - Serum
6
25
2.44
1.25
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
25
2.44
1.25
1.2
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
50
2.05
1.18
1.6
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
34
0.00
1.17
0.0
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
55
433
1.37
1.14
1.7
1.5
nmol/l
21.0
20.9
0.01
49
366
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
104
1.69
1.13
1.5
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
31
2.30
1.11
1.6
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
173
1614
1.43
1.11
25.0
11.1
ml/min/173m2
77.1
77.4
0.06
149
1278
(3009508) Creatinine [Moles/volume] in Urine
70
577
1.32
1.07
2.9
3.1
mmol/l
7.2
7.2
0.04
56
482
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
33
2.16
1.06
2.3
3.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
35
2.03
1.01
1.3
1.2
nmol/l
0.6
1.0
—
7
28
(3015736) pH of Urine
79
668
1.29
1.00
3.0
3.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
184
0.58
0.98
1.3
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
37
1.92
0.95
4.0
1.7
mmol/l
25.7
24.6
—
7
29
(3020682) Albumin/Creatinine [Ratio] in Urine
70
587
1.29
0.93
4.0
3.9
mg/mmol
4.3
7.9
0.67
42
352
(3023183) Ammonium ion [Moles/volume] in Plasma
6
28
2.18
0.92
6.0
1.7
umol/l
31.0
34.7
—
6
20
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
374
1.33
0.91
1.3
1.3
u/ml
0.5
1.9
1.48
12
106
(3029937) Albumin [Presence] in Urine by Test strip
55
450
1.30
0.88
4.3
3.8
estimate
0.0
0.0
0.00
23
145
(3023520) Reticulocytes [#/volume] in Blood
20
137
1.51
0.88
1.9
2.4
e9/l
67.3
64.5
0.17
15
106
(3041096) Erythrocytes [Presence] in Urine by Automated
57
469
1.30
0.87
3.8
3.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
30
2.03
0.87
8.2
3.8
kpa
9.3
8.3
—
6
30
(3013290) Carbon dioxide [Partial pressure] in Blood
6
30
2.03
0.87
8.2
3.8
kpa
5.6
5.1
—
6
30
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
147
1.48
0.84
1.4
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
65
1.73
0.84
1.1
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
98
0.50
0.80
1.6
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
25
0.00
0.79
0.0
1.4
—
74.4
—
0
18
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
28
0.00
0.76
0.0
3.2
—
22.9
—
0
8
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
2.6
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
159
1496
1.27
0.72
27.5
13.1
%
37.9
40.0
1.78
115
1011
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
57
1.60
0.72
1.2
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
26
1.95
0.71
2.6
2.8
e9/l
2.1
4.9
—
5
26
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
42
1.69
0.69
1.1
1.3
e6/l
2.4
217.0
—
7
35
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
42
1.69
0.69
1.1
1.1
e6/l
0.6
3.1
—
7
35
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
27
1.87
0.69
2.6
3.6
%
44.4
61.0
—
5
27
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
243
1.32
0.68
1.5
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
190
1835
1.41
0.66
16.5
8.8
u/l
26.0
24.7
0.69
184
1753
(4010399)
8
128
0.61
0.66
1.1
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
393
1.25
0.64
3.2
3.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
255
1.30
0.63
2.7
2.6
ug/l
0.8
0.7
0.03
21
178
(3022217) INR in Platelet poor plasma by Coagulation assay
29
228
1.32
0.63
9.1
20.0
inr
1.1
1.3
—
5
39
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
36
1.69
0.57
1.5
1.0
—
—
—
0
0
(3010421) pH of Blood
6
37
1.64
0.56
8.3
3.4
ph
7.4
7.4
—
6
30
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
75
669
1.19
0.54
4.0
3.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
170
1.33
0.54
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
53
463
1.19
0.48
5.1
3.9
ug/l
2.0
2.0
0.01
47
413
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
47
1.51
0.48
2.1
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
49
1.44
0.46
1.3
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
50
1.41
0.45
4.3
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
184
1787
1.26
0.44
21.2
11.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
168
1736
0.83
0.43
4.2
4.7
mmol/l
1.5
1.5
1.35
153
1590
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
56
1.45
0.43
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
57
1.42
0.42
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
105
1.36
0.42
2.1
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
364
1.19
0.42
4.6
3.8
%
24.8
24.1
0.07
14
178
(3044290) Cell count panel - Cerebral spinal fluid
5
33
1.53
0.41
1.4
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
45
393
1.19
0.41
1.5
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
162
1677
0.85
0.41
3.7
4.2
mmol/l
1.2
1.3
1.35
150
1524
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
490
1.17
0.40
1.8
1.6
mmol/l
1.4
1.3
0.19
49
413
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
61
1.32
0.40
2.0
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
67
1.36
0.38
1.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
101
943
1.14
0.38
3.0
2.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
36
1.40
0.38
1.0
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
170
1750
0.84
0.37
4.3
4.7
mmol/l
4.5
4.7
1.59
155
1606
(3022621) pH of Urine by Test strip
9
125
0.71
0.36
4.8
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
66
602
1.14
0.35
2.7
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
167
1617
1.17
0.35
5.2
4.8
mu/l
1.9
1.9
0.17
157
1459
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
91
1.34
0.34
2.5
2.2
%
1.1
1.2
0.15
12
91
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
140
1341
1.13
0.34
4.2
4.0
pmol/l
14.6
14.8
0.47
128
1209
(3019225) pH of Specimen
13
165
0.77
0.33
4.0
3.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
128
1.27
0.33
1.1
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
26
221
1.20
0.32
1.3
1.3
titre
354.3
443.6
—
7
56
(3026361) Erythrocytes [#/volume] in Blood
193
1894
1.26
0.32
36.8
17.9
e12/l
4.4
4.5
1.19
188
1831
(3028026) IgM [Mass/volume] in Serum or Plasma
11
84
1.33
0.30
1.2
1.3
g/l
1.4
1.1
0.32
11
78
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
31
270
1.17
0.30
1.5
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
56
1.26
0.29
1.1
1.2
—
—
—
0
0
(4094501)
7
56
1.26
0.29
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
130
1.25
0.29
1.7
1.9
ml/min/173m2
72.4
62.3
—
7
52
(3019309) Folate [Moles/volume] in Red Blood Cells
40
358
1.15
0.28
2.0
1.7
nmol/l
1200.5
1200.8
0.00
30
272
(3007164) IgA [Mass/volume] in Serum or Plasma
36
320
1.15
0.28
1.4
1.2
g/l
2.2
2.5
0.45
27
181
(3019060) Gas panel - Arterial blood
13
105
1.25
0.25
2.5
4.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.1
—
39.9
—
0
6
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
89
1.25
0.21
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
13
0.00
0.21
0.0
1.3
—
23.0
—
0
8
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
170
1665
1.12
0.20
6.7
6.2
mmol/mol
41.1
40.4
0.38
160
1546
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
310
1.12
0.19
1.2
1.3
u/ml
17.2
12.6
0.14
16
107
(1002224) Polysomnography panel
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
319
0.89
0.18
1.3
1.3
iu/ml
13.4
35.4
2.35
14
105
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
92
1.21
0.16
1.1
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
69
724
0.93
0.16
3.8
3.6
ng/l
42.0
85.7
0.42
46
518
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
117
0.85
0.13
1.5
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
176
1783
0.92
0.13
5.0
5.3
mmol/l
2.6
2.7
0.86
160
1628
(3000494) Fungus identified in Specimen by Culture
22
200
1.11
0.13
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
116
0.86
0.12
1.6
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
125
1.13
0.10
1.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
116
1.13
0.09
1.0
1.1
iu/ml
392.5
139.0
—
6
49
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
176
1742
1.07
0.08
4.7
4.8
mmol/l
6.0
6.0
0.12
163
1579
(1761482) Bacteria [#/volume] in Urine by Culture
6
58
1.04
0.08
2.2
3.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
64
0.78
0.08
1.6
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
67
1.05
0.08
1.3
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
74
1.08
0.07
3.8
2.1
—
—
—
0
0
(4034850)
8
75
1.07
0.07
13.1
9.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
78
1.03
0.07
4.3
3.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
84
1.07
0.07
1.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
118
1.11
0.07
1.5
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
387
1.04
0.05
2.1
1.7
pmol/l
398.8
434.1
0.49
30
313
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
108
0.92
0.03
1.5
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
11
106
1.04
0.00
3.5
3.3
kpa
5.4
5.2
0.33
11
95
(3000330) Specific gravity of Urine by Test strip
10
99
1.01
0.00
3.5
3.7
—
—
—
0
0
(3013512) EKG study
54
543
0.99
0.00
3.3
3.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
55
553
0.99
0.00
2.8
2.9
ng/l
1674.8
1081.9
0.34
47
457
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
72
0.97
0.00
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
133.1
—
0
8
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
49
1.02
0.00
1.4
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020891) Body temperature
6
65
0.92
0.00
9.2
4.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
0.00
0.0
3.4
—
68.8
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.3
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
62
0.97
0.00
1.8
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
102.6
—
0
5
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
10.2
—
0
7
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
7.3
—
27.6
—
0
7
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
2.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_DIGESTIVE_NOS_EXALLC – Benign neoplasm: Ill-defined sites within the digestive system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).